1-4 of 4
Philippe Bourget, PharmD, PhD
Close
Sort by
Journal Articles

Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy

Elisa Magrin, PhD, Michaela Semeraro, MD PhD, Alessandra Magnani, MD PhD, Hervé Puy, MD PhD, Annarita Miccio, PhD, Nicolas Hebert, Jean-Sebastien Diana, MD, Francois Lefrere, MD, Felipe Suarez, MD PhD, Olivier Hermine, MD PhD, Valentine Brousse, MD, Catherine Poirot, MD PhD, Philippe Bourget, PharmD, PhD, Wassim El Nemer, PhD, Isabelle Guichard, MD, Despina Moshous, MD PhD, Benedicte Neven, MD, Fabrice Monpoux, MD, Marilyne Poirée, MD, Pablo Bartolucci, MD PhD, Jean-François Meritet, MD, David Grévent, MD, Thibaud Lefebvre, Pharm D.,PhD, Mohammed Asmal, MD PhD, Erin Whitney, MBA, Marisa Gayron, MS, Wenmei Huang, PhD MS, Isabelle Funck-Brentano, PsyD, Mariane de Montalembert, MD PhD, Laure Joseph, MD, Jean-Antoine Ribeil, MD PhD, Marina Cavazzana
Journal: Blood
Blood (2019) 134 (Supplement_1): 3358.
https://doi.org/10.1182/blood-2019-127393
Published: 2019
Journal Articles

Update from the Hgb-205 Phase 1/2 Clinical Study of Lentiglobin Gene Therapy: Sustained Clinical Benefit in Severe Hemoglobinopathies

Jean-Antoine Ribeil, MD PhD, Salima Hacein-Bey-Abina, Pharm.D., PhD, Emmanuel Payen, PhD, Michaela Semeraro, PhD, Magrin Elisa, PhD, Laure Caccavelli, PhD, Fabien Touzot, MD PhD, Francois Lefrere, MD, Felipe Suarez, MD PhD, Olivier Hermine, MD PhD, Valentine Brousse, MD, Catherine Poirot, MD PhD, Benedicte Neven, MD PhD, Philippe Bourget, PharmD, PhD, Wassim El Nemer, PhD, Pablo Bartolucci, MD PhD, Leslie Weber, MSc, Hervé Puy, MD PhD, Jean-François Méritet, PhD, David Grevent, MD, Yves Beuzard, MD, Stany Chrétien, MD, Thibaud Lefebvre, MD, Mohammed Asmal, MD PhD, Marcelyne Joseney-Antoine, Mariane De Montalembert, MD PhD, Stephane Blanche, MD, Philippe Leboulch, MD, Marina Cavazzana, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2311.
https://doi.org/10.1182/blood.V128.22.2311.2311
Published: 2016
Journal Articles

Reiterated Therapeutic Drug Monitoring (TDM) Dosing to Significantly Improve the Control of Exposure to IV Busulfan in Infants and Older Children Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)

Alexandre Amin, PharmD, Philippe Bourget, PharmD, PhD, Benedicte Neven, MD PhD, Marie-Louise Fremond, MD, Martin Castelle, MD, Elodie Elkaim, MD, Guilhem Cros, MD, Despina Moshous, MD, Fabien Touzot, MD, Alexandre Lalli, PharmD, Aurélie Petain, Laurent Nguyen, Stephane Blanche
Journal: Blood
Blood (2015) 126 (23): 4326.
https://doi.org/10.1182/blood.V126.23.4326.4326
Published: 2015
Journal Articles

Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo with a Lentiviral Beta AT87Q-Globin Vector

Marina Cavazzana, MD PhD, Jean-Antoine Ribeil, MD PhD, Emmanuel Payen, MD, Felipe Suarez, MD PhD, Yves Beuzard, MD, Fabien Touzot, MDPhD, Resy Cavallesco, PhD, Francois Lefrere, MD, Stany Chretien, MD, Philippe Bourget, PharmD, PhD, Fabrice Monpoux, MD, Corinne Pondarre, Benedicte Neven, Manfred Schmidt, PhD, Christof von Kalle, MD, Frans A. Kuypers, PhD, Laura Sandler, MPH, Sandeep Soni, MD, Olivier Hermine, Stephane Blanche, MD, Mariane De Montalembert, MD, Salima Hacien-Bey-Abina, PharmD, PhD, Philippe Leboulch, MD
Journal: Blood
Blood (2015) 126 (23): 202.
https://doi.org/10.1182/blood.V126.23.202.202
Published: 2015